- Home
- YALA vs VALN Comparison
YALA vs VALN Comparison
Compare YALA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YALA
- VALN
- Stock Information
- Founded
- YALA 2016
- VALN 2012
- Country
- YALA United Arab Emirates
- VALN France
- Employees
- YALA N/A
- VALN N/A
- Industry
- YALA Computer Software: Programming Data Processing
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YALA Technology
- VALN Health Care
- Exchange
- YALA Nasdaq
- VALN Nasdaq
- Market Cap
- YALA 689.5M
- VALN 595.2M
- IPO Year
- YALA 2020
- VALN 2021
- Fundamental
- Price
- YALA $4.24
- VALN $7.44
- Analyst Decision
- YALA
- VALN Strong Buy
- Analyst Count
- YALA 0
- VALN 2
- Target Price
- YALA N/A
- VALN $17.00
- AVG Volume (30 Days)
- YALA 189.3K
- VALN 83.7K
- Earning Date
- YALA 03-10-2025
- VALN 03-20-2025
- Dividend Yield
- YALA N/A
- VALN N/A
- EPS Growth
- YALA 31.83
- VALN N/A
- EPS
- YALA 0.74
- VALN N/A
- Revenue
- YALA $329,773,319.00
- VALN $176,817,979.00
- Revenue This Year
- YALA $6.23
- VALN $22.73
- Revenue Next Year
- YALA $11.04
- VALN $11.39
- P/E Ratio
- YALA $5.73
- VALN N/A
- Revenue Growth
- YALA 5.34
- VALN N/A
- 52 Week Low
- YALA $3.71
- VALN $3.62
- 52 Week High
- YALA $5.54
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- YALA 70.20
- VALN 60.56
- Support Level
- YALA $4.12
- VALN $6.62
- Resistance Level
- YALA $4.25
- VALN $8.42
- Average True Range (ATR)
- YALA 0.10
- VALN 0.46
- MACD
- YALA 0.03
- VALN 0.05
- Stochastic Oscillator
- YALA 90.42
- VALN 69.85
About YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.